Massachusetts legislation · 194th General Court
Massachusetts H4943: An Act relative to epinephrine injectors
Status: In committee, July 29, 2026
What the bill says
From the introduced text, January 23, 2026:
SECTION 1. Chapter 32A of the General Laws is hereby amended by inserting after section 17Z the following section:- Section 17AA. Any coverage offered by the commission to an active or retired employee of the commonwealth insured under the group insurance commission shall provide coverage for the appropriate weight-based dosage of epinephrine injectors. The benefits in this section shall not be subject to any greater deductible, coinsurance, copayments, or out-of-pocket limits than any other benefit provided by the commission. For purposes of this section the term “epinephrine injector” shall mean an auto-injector approved by the federal Food and Drug Administration for the administration of epinephrine and a pre-filled syringe approved by the federal Food and Drug Administration and used for the administration of epinephrine that contains a pre-measured dose of epinephrine that is equivalent to the dosages used in an auto-injector. SECTION 2. Chapter 118E of the General Laws is hereby amended by inserting after section 10Z the following section:- Section 10AA. The division and its contracted health insurers, health plans, health maintenance organizations, behavioral health management firms, and third-party administrators under contract to a Medicaid-managed care organization or primary care clinician plan shall provide coverage for the appropriate weight-based dosage of epinephrine injectors. An epinephrine injector prescribed in this section shall not be subject to any greater deductible, coinsurance, …
Sponsors
- Services, Joint Committee on Financial (I) · primary sponsor
- Patrick Kearney (D, 4th Plymouth)
- Hannah Kane (R, 11th Worcester)
- Todd Smola (R, 1st Hampden)
- Paul Frost (R, 7th Worcester)
- Kimberly Ferguson (R, 1st Worcester)
- Bradley Jones (R)
Latest actions
- : Committee recommended bill ought to pass and referred to the committee on House Ways and Means
- : Reporting date extended to Thursday, December 31, 2026
- : Reported favorably by committee and referred to the committee on Health Care Financing
- : New draft of H1206
- : Reported from the committee on Financial Services
Votes
- Committee Vote - Joint Committee on Health Care Financing (July 16, 2026): 13 yea, 0 nay, passed
- Committee Vote - Joint Committee on Financial Services (January 5, 2026): 11 yea, 0 nay, passed
Common questions
- What is H4943?
- H4943 is a bill in the Massachusetts Legislature (194th General Court): An Act relative to epinephrine injectors.
- What is the status of H4943?
- In committee as of July 29, 2026. Latest action: Committee recommended bill ought to pass and referred to the committee on House Ways and Means (July 29, 2026).
- Who sponsored H4943?
- Services, Joint Committee on Financial (I), with 6 co-sponsors.
- Where is the official record for H4943?
- On the Massachusetts Legislature website: https://malegislature.gov/Bills/194/H4943
Source: official Massachusetts record. Tracked by Delilah, AI for legislation across all 50 states and Congress.